DSC, FT-IR and NIR with Chemometric Assessment Using PCA and HCA for Estimation of the Chemical Stability of Oral Antidiabetic Drug Linagliptin in the Presence of Pharmaceutical Excipients

Molecules. 2022 Jul 3;27(13):4283. doi: 10.3390/molecules27134283.

Abstract

Pharmaceutical excipients should not interact with active substances, however, in practice, they sometimes do it, affecting the efficacy, stability and safety of drugs. Thus, interactions between active substances and excipients are not desirable. For this reason, two component mixtures of oral antidiabetic drug linagliptin (LINA) with four excipients of different reactivity, i.e., lactose (LAC), mannitol (MAN), magnesium stearate (MGS) and polyvinylpyrrolidone (PVP), were prepared in a solid state. A high temperature and a high humidity of 60 °C and 70% RH, respectively, were applied as stressors in order to accelerate the potential interactions between LINA and excipients. Differential scanning calorimetry (DSC) as well as Fourier transform infrared (FT-IR) and near infrared (NIR) spectroscopy were used to estimate the changes due to potential interactions. In addition, chemometric computation of the data with principal component analysis (PCA) and hierarchical cluster analysis (HCA) was applied to adequately interpret the findings. Of the excipients used in the present experiment, all of them were not inert in relation to LINA. Some of the interactions were shown without any stressing, whereas others were observed under high-temperature/high-humidity conditions. Thus, it could be concluded that selection of appropriate excipients for LINA is very important question to minimize its degradation, especially when new types of formulations with LINA are being developed and manufactured.

Keywords: DSC; FT-IR; NIR; chemometrics; excipients; high temperature/high humidity; interactions; linagliptin.

MeSH terms

  • Calorimetry, Differential Scanning
  • Chemometrics
  • Cluster Analysis
  • Drug Stability
  • Excipients* / chemistry
  • Fourier Analysis
  • Humans
  • Hypoglycemic Agents
  • Linagliptin*
  • Principal Component Analysis
  • Spectroscopy, Fourier Transform Infrared / methods

Substances

  • Excipients
  • Hypoglycemic Agents
  • Linagliptin

Grants and funding

This research received no external funding.